<p>Individuals diagnosed with type 2 diabetes mellitus(T2DM) are more likely to develop sarcopenia. Sarcopenia is one of the new complications that lead to decreased muscle strength and mass. The objective of the present study is to evaluate the correlation between calf circumference and skeletal mass index among T2DM participants with sarcopenia. This study included 62 individuals diagnosed with T2DM with Sarcopenia aged between 40 and 70 years. The examiner noted demographic details, including age, sex, height, weight, and BMI. The correlation between skeletal mass index and calf circumference was analyzed using Spearman’s correlation. The mean age of the 29 female participants in this study was 58.2 ± 8.57 years, and the 33 males were 61.1 ± 8.37 years. A significant positive moderate correlation between calf circumference and skeletal mass index was found (Spearman’s <i>r</i> = 0.58 for females and 0.62 for males, respectively, <i>p</i> &lt; 0.001). The multivariable linear regression model was statistically significant (R² = 0.556, adjusted R² = 0.515, F(5,54) = 13.547, <i>p</i> &lt; 0.001). Assessment of calf circumference is a feasible, easy-to-incorporate, and cost-effective way to screen patients with T2DM and sarcopenia, and it can be incorporated into tertiary healthcare settings.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Correlation between calf circumference and skeletal mass index among type 2 diabetes mellitus individuals with sarcopenia

  • Deeksha Shettigar,
  • G. Arun Maiya,
  • Sahana Shetty,
  • K. V. Rajagopal,
  • Rama Bhat,
  • Vasudeva Acharya,
  • Shreemathi S. Mayya,
  • Shetty Shrija Jaya

摘要

Individuals diagnosed with type 2 diabetes mellitus(T2DM) are more likely to develop sarcopenia. Sarcopenia is one of the new complications that lead to decreased muscle strength and mass. The objective of the present study is to evaluate the correlation between calf circumference and skeletal mass index among T2DM participants with sarcopenia. This study included 62 individuals diagnosed with T2DM with Sarcopenia aged between 40 and 70 years. The examiner noted demographic details, including age, sex, height, weight, and BMI. The correlation between skeletal mass index and calf circumference was analyzed using Spearman’s correlation. The mean age of the 29 female participants in this study was 58.2 ± 8.57 years, and the 33 males were 61.1 ± 8.37 years. A significant positive moderate correlation between calf circumference and skeletal mass index was found (Spearman’s r = 0.58 for females and 0.62 for males, respectively, p < 0.001). The multivariable linear regression model was statistically significant (R² = 0.556, adjusted R² = 0.515, F(5,54) = 13.547, p < 0.001). Assessment of calf circumference is a feasible, easy-to-incorporate, and cost-effective way to screen patients with T2DM and sarcopenia, and it can be incorporated into tertiary healthcare settings.